www.pureims.com RODEN, the Netherlands, April 3, 2023 /PRNewswire/ — PureIMS, a pharmaceutical company focused on the development of dry-powder inhalation products with its proprietary Cyclops™ inhaler, today announced it has secured a new investment round. New investor Boost-UP…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.